A week on from mHealth in London, Pauline and Shiyan attended the Clinical Trial Innovation Programme in Frankfurt. Further showcasing SQN Health to the European market, introducing the concept of wellness and how we can make a trial truly patient centric.
With amazing views of the river Main and lovely sunny weather, the CTIP conference kicked off on Thursday 26th April 2018 in Frankfurt. Provoking thoughts and discussion, Pauline spoke on “Elevating clinical research – An innovative approach to data collection, patient centricity and clinical oversight.”
This included incorporation of Wellness and communication into our ePRO application. With a positive reception to the innovative advancement SQN are making, many were intrigued how wellness could be included in study design and implemented into a trial. With the advanced oversight and a better understanding of the patient in a trial, we shift our patient centric approach to help a patient feel more included.
Congratulations to Torsten Hoffman, Silence Therapeutics for winning the infamous Chocoholic survival kit.
A big thank you must also go to the team at World Bi who made our experience at the conference a special one as well as Jörg Schommer for drawing the the prize.
We are next showcasing at the T3: Trials, Tech and Transformation conference, with more chocolate, a large phone and another talk from Shiyan Caan on SQN’s experience of patient centric trials and how we can further adapt to the evolving paradigm in clinical research.
HIGH QUALITY, LOW RISK AND TRUST…IS SIMPLY A CHOICE
SQN is one of the worlds recognised specialist clinical biometrics CROs supporting global pharma, biotech, medical device and animal health partners with innovative, cost effective clinical development services.
Pharmaceutical and biotech companies are under immense pressure to continue to develop life-changing treatments, whilst reducing cost and time to market to increase the margin for return on investment. If...
Electronic data capture systems revolutionised how we collect data in clinical trials increasing efficiencies and improving the quality of the data. However, two decades on, the marketplace is now saturated...